park_nano_research_grant.jpg

Camouflaged nanoparticles used to deliver killer protein to cancer



A biomimetic nanosystem can deliver therapeutic proteins to selectively target cancerous tumors, according to a team of Penn State researchers.

Using a protein toxin called gelonin from a plant found in the Himalayan mountains, the researchers caged the proteins in self-assembled metal-organic framework (MOF) nanoparticles to protect them from the body’s immune system. To enhance the longevity of the drug in the bloodstream and to selectively target the tumor, the team cloaked the MOF in a coating made from cells from the tumor itself.

Blood is a hostile environment for drug delivery. The body’s immune system attacks alien molecules or else flushes them out of the body through the spleen or liver. But cells, including cancer cells, release small particles called extracellular vesicles that communicate with other cells in the body and send a “don’t eat me” signal to the immune system.

“We designed a strategy to take advantage of the extracellular vesicles derived from tumor cells,” said Siyang Zheng, associate professor of biomedical and electrical engineering at Penn State. “We remove 99 percent of the contents of these extracellular vesicles and then use the membrane to wrap our metal-organic framework nanoparticles. If we can get our extracellular vesicles from the patient, through biopsy or surgery, then the nanoparticles will seek out the tumor through a process called homotypic targeting.”

Gong Cheng, lead author on a new paper describing the team’s work and a former postdoctoral scholar in Zheng’s group now at Harvard, said, “MOF is a class of crystalline materials assembled by metal nodes and organic linkers. In our design, self-assembly of MOF nanoparticles and encapsulation of proteins are achieved simultaneously through a one-pot approach in aqueous environment. The enriched metal affinity sites on MOF surfaces act like the buttonhook, so the extracellular vesicle membrane can be easily buckled on the MOF nanoparticles. Our biomimetic strategy makes the synthetic nanoparticles look like extracellular vesicles, but they have the desired cargo inside.”

The nanoparticle system circulates in the bloodstream until it finds the tumor and locks on to the cell membrane. The cancer cell ingests the nanoparticle in a process called endocytosis. Once inside the cell, the higher acidity of the cancer cell’s intracellular transport vesicles causes the metal-organic framework nanoparticles to break apart and release the toxic protein into cytosol and kill the cell.

“Our metal-organic framework has very high loading capacity, so we don’t need to use a lot of the particles and that keeps the general toxicity low,” Zheng said.

The researchers studied the effectiveness of the nanosystem and its toxicity in a small animal model and reported their findings in a cover article in the Journal of the American Chemical Society.

The researchers believe their nanosystem provides a tool for the targeted delivery of other proteins that require cloaking from the immune system. Penn State has applied for patent protection for the technology

Self-Assembly of Extracellular Vesicle-like Metal−Organic Framework Nanoparticles for Protection and Intracellular Delivery of Biofunctional Proteins Gong Cheng, Wenqing Li, Laura Ha, Xiaohui Han, Sijie Hao, Yuan Wan, Zhigang Wang, Fengping Dong, Xin Zou, Yingwei Mao, and Si-Yang Zheng J. Am. Chem. Soc (2018) DOI: 10.1021/jacs.8b03584

Contact information:

Siyang Zheng, Dr College of Engineering, Biomedical Engineering sxz10@psu.edu Tel: 814-865-8090

Pennsylvania State University

#Cancer #Nanoparticles #Nanosystems

 

STAY CURRENT WITH THE NWA NEWSLETTER DELIVERED TO YOUR INBOX.

FOUNDING MEMBERS

A replaceable, more efficient filter for N95 masks

New wearable sensor tracks vitamin C levels in sweat

Nanobowls serve up chemotherapy drugs to cancer cells

VR and AR devices at 1/100 the cost and 1/10,000 the thickness in the works

The first tunable, chip-based 'vortex microlaser' and detector

New technology can detect anti-virus antibody in 20 minutes

The broadest microcomb spectral span on record

[PALD] SUMMIT is a live digital conference on surface engineering via Particle Atomic Layer Deposition

 

When:     MAY 21st 2020

Where:    ONLINE

Cost:       FREE

PaldSUMMITLogo.jpg